Johnson & Johnson (JNJ) announced that it will present data across its neuropsychiatry portfolio at the 2026 Psych Congress Annual Meeting.
The presentation is scheduled to take place on September 8, 2026, at 8:03 AM ET.
The company did not disclose specific data points, trial results, or product names in the provided text.
